CIK 0002012593 · Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
Rapport Therapeutics, Inc.
Sign in to watch- Ticker
- RAPP
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 880724208
- Phone
- 857-321-8020
- Business address
- 99 HIGH STREET, SUITE 2100, BOSTON, MA, 02110
- Former names
- Rapport Therapeutics, Inc.
- 4 Planned sale Chief Executive Officer sold 2,210 shares at an average $42.11 ($93,061)
- 4 Planned sale Chief Executive Officer sold 8,210 shares at an average $40.00 ($328,437)
- 4 Planned sale Chief Operating Officer sold 10,000 shares at an average $41.58 ($415,798)
- 4 Planned sale Chief Executive Officer sold 8,220 shares at an average $39.83 ($327,398)
- 144 Insider Sale of Securities
- 144 Insider Sale of Securities
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 8-K Event Shareholder vote results
- 4 Planned sale 10% owner sold 18,572 shares at $40.05 ($743,753)
- 144 Insider Sale of Securities
- SCHEDULE 13G/A Stake Statement of Beneficial Ownership
- 4 Planned sale 10% owner sold 133,618 shares at $40.24 ($5,377,323)
- 4 Planned sale 10% owner sold 276,513 shares at an average $40.12 ($11,094,906)
Page 3 of 13 · 253 filings